Creatine and Creatinine Metabolism - Physiological Reviews
Creatine and Creatinine Metabolism - Physiological Reviews
Creatine and Creatinine Metabolism - Physiological Reviews
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
1146 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80<br />
Ca 2� -induced increase in rate-pressure product was<br />
strongly depressed, [ATP] declined significantly while<br />
[PCr] was maintained, <strong>and</strong> CK activity was reduced to 39%<br />
of control. Therefore, NO can regulate contractile reserve,<br />
possibly by reversible nitrosothiol modification of CK at<br />
the reactive Cys residue identified in previous investigations<br />
(see Ref. 275).<br />
5) In isolated perfused hearts of transgenic mice<br />
lacking both M-CK <strong>and</strong> sarcomeric Mi-CK, with a 96%<br />
decrease in total CK activity, [ADP] was significantly<br />
higher during baseline perfusion than in controls (848).<br />
Increasing heart rate <strong>and</strong> perfusate [Ca 2� ] caused no<br />
differences in cardiac contractile response or myocardial<br />
oxygen consumption but increased [ADP] <strong>and</strong> decreased<br />
the free energy of ATP hydrolysis significantly more in<br />
CK-deficient than in control hearts. Consequently, cardiac<br />
work is more “energetically costly” in hearts with low CK<br />
activity (see also sect. VIID).<br />
6) As described in detail in section VIIIB, GPA or<br />
3-GBA feeding is a means of depleting the Cr <strong>and</strong> PCr<br />
stores of a tissue. Again, no differences were found in the<br />
basic characteristics of contraction <strong>and</strong> relaxation among<br />
the hearts of control, GPA-treated, <strong>and</strong> 3-GBA-treated rats<br />
at low workloads. At high workloads, however, a series of<br />
functional deficits became apparent. Hearts from GPA- or<br />
3-GBA-fed animals displayed a decrease in maximal work<br />
capacity (456, 457, 517, 754, 1163), a considerable decrease<br />
in the length of time during which 75% of the<br />
maximal cardiac output could be maintained (91), a decrease<br />
in right ventricular (RV) <strong>and</strong> left ventricular (LV)<br />
systolic pressure <strong>and</strong>, hence, mean aortic pressure (4,<br />
456–458, 754, 1163), an increase in RV <strong>and</strong> LV (end)<br />
diastolic pressure <strong>and</strong> stiffness (91, 456–458, 754), as well<br />
as delayed kinetics of pressure development <strong>and</strong> relaxation<br />
(4, 456, 501, 754). Increased LV stiffness <strong>and</strong> incomplete<br />
myocardial relaxation may impair LV filling <strong>and</strong> may<br />
thus be the underlying cause of the diminished cardiac<br />
output at high workloads. Furthermore, Mi-CK activity<br />
<strong>and</strong> Cr-stimulated mitochondrial respiration were depressed<br />
in GPA-treated hearts (130, 458, 718–720, 754).<br />
Electron microscopic examination revealed structural abnormalities<br />
of both myofilaments <strong>and</strong> mitochondria (91,<br />
718–720). Only in some investigations, GPA feeding induced<br />
cardiac hypertrophy (130, 135, 631). The fact that<br />
functional deficits of GPA-treated hearts were observed in<br />
some studies but not in others (888) may be due to<br />
different extents of Cr depletion <strong>and</strong> to different maximal<br />
workloads imposed. As a matter of fact, cardiac work <strong>and</strong><br />
the rates of pressure development <strong>and</strong> relaxation were<br />
shown in rat heart to decrease only when total Cr was<br />
reduced to �20% of control (456, 517).<br />
7) All these experimental findings have recently<br />
gained theoretical support, in as far as mathematical modeling<br />
revealed that in the systolic phase of the rat <strong>and</strong><br />
mouse cardiac cycle, all CK isoenzymes may be displaced<br />
from chemical equilibrium (11, 831). This, again, signifies<br />
that CK does not merely serve a backup role for buffering<br />
[ATP] <strong>and</strong> [ADP] in the rat heart but that it may critically<br />
determine high-energy phosphate transport within the<br />
cells.<br />
Although all approaches discussed so far have provided<br />
a consistent <strong>and</strong> convincing picture, it shall not be<br />
ignored that some authors have arrived at contradictory<br />
results (e.g., Refs. 470, 614, 782, 1048) <strong>and</strong> that several<br />
approaches (e.g., inhibition of CK by iodoacetamide or<br />
DNFB; GPA administration) may not be sufficiently specific<br />
to have the CK/PCr/Cr system as their only target.<br />
Even more importantly, the results obtained on the rat<br />
heart cannot necessarily be extrapolated to the human<br />
heart since the cardiac CK/PCr/Cr system <strong>and</strong> energy<br />
metabolism in general differ considerably between the<br />
two species (see Refs. 402, 824). The rat heart displays<br />
lower total CK activity, a lower proportion of MM-CK, <strong>and</strong><br />
higher proportions of Mi-CK <strong>and</strong> MB-CK than the human<br />
heart (60, 30, <strong>and</strong> 10% vs. 90%, 10%, <strong>and</strong> trace amounts).<br />
In case the correlation between the capacity of the<br />
CK/PCr/Cr system <strong>and</strong> cardiac performance is accepted, it<br />
might also be anticipated that cardiac disease is intimately<br />
linked with disturbances in CK function <strong>and</strong>/or Cr<br />
metabolism, with these disturbances representing either<br />
an expression or, conversely, the underlying cause of the<br />
pathological condition. In fact, alterations of the CK/<br />
PCr/Cr system present themselves as one of the key characteristics<br />
of cardiac disease <strong>and</strong> have been observed in<br />
various animal models, e.g., the spontaneously hypertensive<br />
rat (68, 400, 403, 404, 882); the hypertensive <strong>and</strong><br />
hypotensive rat of the Lyon strain (575); the hyperthyroid<br />
rat (55, 400, 403, 576, 875); in rat diabetic cardiomyopathy<br />
(see Refs. 38, 458, 611, 658, 777, 854, 955, 988, 1060); in<br />
pressure-overload hypertrophy induced in the rat by aortic<br />
b<strong>and</strong>ing, pulmonary b<strong>and</strong>ing, or clipping of the renal<br />
artery (35, 256, 400, 401, 752, 914, 1007); in rat cardiomyopathies<br />
induced by the drugs adriamycin (� doxorubicin),<br />
norepinephrine, or isoprenaline (38, 457, 458, 703,<br />
812); in hereditary dilated or hypertrophic cardiomyopathy<br />
of the Syrian hamster (38, 107, 458, 476, 599, 689, 832,<br />
1008, 1058, 1060); in right ventricular hypertrophy <strong>and</strong><br />
failure in the cat due to constriction of the main pulmonary<br />
artery (775); in cardiac hypertrophy due to pressure<br />
or volume overload in the dog (33, 40, 400, 401, 404, 737,<br />
865, 1159); in a guinea pig model of autoimmune cardiomyopathy<br />
(863); in turkey poults with furazolidone-induced<br />
cardiomyopathy (117, 558); as well as in hypertrophied<br />
baboon heart (for reviews see Refs. 55, 401, 739,<br />
1058). Disturbances in the CK/PCr/Cr system were also<br />
found in patients with LV hypertrophy due to aortic stenosis,<br />
in patients with coronary artery disease with <strong>and</strong><br />
without hypertrophy, <strong>and</strong> in patients with aortic valve<br />
disease, mitral regurgitation, <strong>and</strong> dilated cardiomyopathy<br />
(139, 403, 425, 476, 690, 778, 832, 967; for reviews <strong>and</strong>